Bristol Myers Squibb (BMYMP) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $4.0 billion.
- Bristol Myers Squibb's Accumulated Depreciation & Amortization fell 5821.88% to $4.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.0 billion, marking a year-over-year decrease of 5821.88%. This contributed to the annual value of $4.0 billion for FY2025, which is 5821.88% down from last year.
- According to the latest figures from Q4 2025, Bristol Myers Squibb's Accumulated Depreciation & Amortization is $4.0 billion, which was down 5821.88% from $3.0 billion recorded in Q3 2025.
- Over the past 5 years, Bristol Myers Squibb's Accumulated Depreciation & Amortization peaked at $10.7 billion during Q4 2021, and registered a low of $1.0 billion during Q1 2025.
- Over the past 5 years, Bristol Myers Squibb's median Accumulated Depreciation & Amortization value was $5.1 billion (recorded in 2022), while the average stood at $5.6 billion.
- Per our database at Business Quant, Bristol Myers Squibb's Accumulated Depreciation & Amortization skyrocketed by 771.09% in 2021 and then plummeted by 6069.95% in 2025.
- Over the past 5 years, Bristol Myers Squibb's Accumulated Depreciation & Amortization (Quarter) stood at $10.7 billion in 2021, then fell by 3.84% to $10.3 billion in 2022, then dropped by 5.02% to $9.8 billion in 2023, then decreased by 1.64% to $9.6 billion in 2024, then crashed by 58.22% to $4.0 billion in 2025.
- Its last three reported values are $4.0 billion in Q4 2025, $3.0 billion for Q3 2025, and $2.0 billion during Q2 2025.